ライフサイエンスコーパス: mediastinal lymphadenopathy

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 ary lesions in the lungs along with necrotic mediastinal lymphadenopathy.

2 ted Castleman disease manifests with diffuse mediastinal lymphadenopathy.

3 At CT, all lesions manifested with diffuse mediastinal lymphadenopathy.

4 ilar lymphadenopathy, mediastinal masses, or mediastinal lymphadenopathy.

5 One patient with a mediastinal mass also had mediastinal lymphadenopathy.

6 pital for examination of bilateral hilar and mediastinal lymphadenopathy.

7 Patients with isolated mediastinal lymphadenopathy (IML) are a common presentat

8 FDG-PET also accurately characterized hilar/mediastinal lymphadenopathy in 12 patients with associat

9 Transthoracic needle biopsy of mediastinal lymphadenopathy is a safe, accurate diagnost

10 EUS detected malignant mediastinal lymphadenopathy more frequently in patients

11 and more interlobular septal thickening and mediastinal lymphadenopathy on computed tomography of th

12 enty-six patients with NSCLC with absence of mediastinal lymphadenopathy on CT were enrolled and foll

13 rasound (EUS) in staging NSCLC in absence of mediastinal lymphadenopathy on CT.

14 rdial delayed enhancement of the septum, and mediastinal lymphadenopathy should raise the suspicion f

15 osed in 5 of 77 patients (6.5%), while hilar/mediastinal lymphadenopathy was found in 25 of 76 patien

16 In 29 patients, endoscopic US-guided FNAB of mediastinal lymphadenopathy was performed as a component

17 rdial delayed enhancement of the septum, and mediastinal lymphadenopathy were more often see in those

18 Eighty-six consecutive patients with mediastinal lymphadenopathy who did not have a primary g

19 o guide TBNA in 12 consecutive patients with mediastinal lymphadenopathy who had previously undergone

20 (PET) scan confirmed the lung lesion and the mediastinal lymphadenopathy without distant metastases.

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。